D-802-2013 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-802-2013 was initiated by American Health Packaging on Oct 10, 2012 and is designated Class II. Reason for recall: Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg. The recall status is terminated (terminated Aug 21, 2013). Affected quantity: 19060 blister cards.

Recall details

Product Type
Drugs
Report Date
Jul 24, 2013
Initiation Date
Oct 10, 2012
Termination Date
Aug 21, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19060 blister cards

Product description

QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01

Reason for recall

Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Distribution pattern

Nationwide

Code information

Lot 122600 Exp. 03/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-802-2013
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-802-2013. Report a data issue: hello@regdatalab.com.